Navigation Links
Plant pathogen yields substance to fight neuroblastoma
Date:1/17/2008

Drug treatment of neuroblastoma, a tumor of the nervous system in children, poses major problems. Therefore, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been searching for substances that are suitable as a basis for developing better drugs. Now they have found a candidate: HC-toxin, which is isolated from a fungal plant pathogen. The substance from the maize pathogen reprograms neuroblastoma cells in such a way that they behave almost like healthy cells again.

Normally, the fungus Helminthosporium carbonum leads to reduced harvests for maize farmers. Yet a specific constituent of the pathogen, namely HC-toxin, might be very useful for medicine. The substance is used by scientists as a basis for developing a new anti-cancer drug. HC-toxin acts on enzymes known as histone deacetylases (HDACs), which structure the packaging of the genetic material, or DNA. HDAC enzymes change, among others, the histones proteins around which the DNA is wrapped. Alterations in the packaging of the genetic material are suspected to cause cancer or promote its spread. Therefore, scientists are studying substances that inhibit HDAC enzymes for their ability to fight malignant tumors.

Among these substances is HC-toxin, which has now been investigated by researchers of the Clinical Cooperation Unit Pediatric Oncology at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). They found out that neuroblastoma cells lose several of their cancer-typical properties when under the influence of the substance: They divide less frequently, show less invasive growth and even their outside appearance resembles healthy nerve cells again. These effects were observed to be stronger than with other HDAC inhibitors investigated previously.

The effect of HC-toxin is presumably based, among other things, on the fact that it promotes the function of an important cellular cancer brake known as RB signalin
'/>"/>

Contact: Dr. Sibylle Kohlstdt
s.kohlstaedt@dkfz.d
49-622-142-2843
Helmholtz Association of German Research Centres
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Study provides hope that some transplant patients could live free of antirejection drugs
3. Study provides hope that some transplant patients could live free of anti-rejection drugs
4. Advanced Age No Bar to Liver Transplant
5. Nanowire coating for bone implants, stents
6. Circulating fats kill transplanted pancreas cells, study shows
7. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
8. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
9. Implantable device designed to detect, stop seizures under study at MCG
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. Bone-growing nanomaterial could improve orthopaedic implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... of internal medicine residents at Massachusetts General Hospital (MGH) ... found that more than half rated the training they ... as fair or poor. Significant numbers felt unprepared to ... of practicing physicians. In response to the findings, recently ... the MGH has increased residents, training in addiction medicine. ...
(Date:5/22/2013)... father,s depression have on his young son or daughter? When ... marriage, their children benefit, said a University of Illinois study. ... need to be able to attend to the child,s emotional ... and notice whether he is getting frustrated or needs help. ... a U of I professor of human development. , But ...
(Date:5/22/2013)... IL A new study suggests that disturbed ... of depression and greater uncertainly about future success. ... and teachers appears to have a protective effect. ... significantly associated with depressed mood and greater uncertainty ... from parents and from teachers were associated with ...
(Date:5/22/2013)... plants" that make energy to keep cells alive is ... the drug-resistant forms of cancer source of a ... of a new study published in the journal ... colleagues explain that doxorubicin and other common forms of ... of cancer cells. Cancer cells divide and multiply faster ...
(Date:5/22/2013)... The newest member of TeethWhiteningforFree.com is Dr. ... Alabama graduate, Dr. Sanderson provides professional dental care to ... he extends complimentary teeth whitening to his patients who ... up. Only a dental professional can decide if the ... , Teeth whitening is an easy way ...
Breaking Medicine News(10 mins):Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2
... A Closer Look at The Value of,MRIs ... of,America,s (MSAA) website, http://www.msassociation.org . This three ... offering a first-hand,account on the experience of undergoing ... well as the importance of MRIs to monitor ...
... N.C., June 5 Benchmarking is not a luxury;,it ... climates. This research,excerpt presents a survey analysis of 30 ... how companies are using benchmarking in a,difficult economy., ... companies are,choosing to benchmark, the goals of benchmarking studies, ...
... The Massachusetts School of,Professional Psychology, WEST ROXBURY, ... state about the ,invisible wounds of war, - ... depression and post traumatic,stress disorder (PTSD) - which ... and suicide. We need to begin focusing on ...
... information, giveaways, entertainment and ... ... with professional fitness and figure competitors Allison,Frahn and Tina Durkin, will represent ... Cobb Galleria Centre in Atlanta., Chad, part of the World Natural ...
... Cline Davis & Mann (CDM), a ... of its,newest division, Platform Advisors(TM). Platform Advisors, ... and scientific consulting,services for pharmaceutical, biotechnology, and ... firms, Platform Advisors combines the,expertise of seasoned ...
... barriers cited, particularly in construction jobs, CDC reports ... workers face a greater risk of dying from ... in the construction industry, U.S. health officials said ... workers died from work-related injuries. This represents approximately ...
Cached Medicine News:Health News:Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs 2Health News:Demonstrating the Value of Benchmarking in an Uncertain Economy 2Health News:Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans 2Health News:Rite Aid Health and Beauty Expo to Showcase GNC Athletes 2Health News:Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry 2Health News:Hispanic Workers Dying at Higher Rates Than Others 2Health News:Hispanic Workers Dying at Higher Rates Than Others 3
(Date:5/22/2013)... and TORONTO , May ... (OTCBB: GNBT) today announced three presentations demonstrating the superiority ... its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ). ... of the American Society of Clinical Oncology (ASCO) to ... May 31 through June 4, 2013. The ...
(Date:5/22/2013)... Mai 2013  Grifols, ein globales Unternehmen ... Barcelona , Spanien, präsentierte die Ergebnisse ... Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel ... auf ein Niveau anhebt, das innerhalb des ... ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, bei ...
(Date:5/22/2013)... , May 22, 2013  Medifocus, Inc. (OTCQX: MDFZF and ... , Chief Operating Officer, will present at the Second Annual ... New York City at the Grand ... to begin at 4:00 p.m. EDT and will be available ...   http://wsw.com/webcast/marcum/mfs.v/   For more information and registration, ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3
... Oct. 20 Young Innovations, Inc. (Nasdaq: YDNT ) ... quarter and the nine-months ended September 30, 2010. ... increase of 6.5% over the $24.8 million reported for the third ... 7.6% to $6.1 million from $5.7 million in the prior year ...
... INDIANAPOLIS, Oct. 20 MacroGenics, Inc. and Eli Lilly ... that the Protege Data Monitoring Committee (DMC), composed of ... has completed a planned analysis of one-year safety and ... of teplizumab, an investigational biologic under development for the ...
Cached Medicine Technology:Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 2Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 3Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 4Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend 5MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 2MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 3
... SpecTRACK Software is an Informatics software product ... of specimens for the laboratory. With SpecTRACK ... location of any specimen from all laboratories ... in the refrigerator or cold room. Automate ...
PediaVision LLC is a life sciences company dedicated to solving the critical problem of undiagnosed vision problems affecting children worldwide....
... only contact lenses designed to address two ... eyes: presbyopia and eye dryness. , Only ... design, Balanced Progressive Technology, with a unique ... Technology. The result? Lenses that give you ...
... encountered complication in cataract surgery. Should a ... many surgeons advocate the use of flexible iris ... for maximum visibility during the procedure. These ... and can be easily inserted through four evenly ...
Medicine Products: